This is the case of the cancer immunogram, which aims to classify tumors according to immune parameters previously associated with the response to immunotherapy, including mutational load, lymphocyte infiltration, absence of checkpoints or soluble inhibitors, response to immune effectors such as IFNγ, and tumor metabolism. The gene discussed is IFNG; the disease is cancer.